14-day Premium Trial Subscription Try For FreeTry Free
$13.15
-0.290 (-2.16%)
At Close: Apr 23, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $12.77 $17.80 Tuesday, 23rd Apr 2024 ENTA stock ended at $13.15. This is 2.16% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.14% from a day low at $13.04 to a day high of $13.71.
90 days $11.01 $17.80
52 weeks $8.08 $37.75

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
Aug 11, 2023 $16.26 $16.46 $15.85 $15.89 187 476
Aug 10, 2023 $16.81 $17.04 $16.27 $16.40 174 765
Aug 09, 2023 $17.35 $17.35 $16.28 $16.70 240 633
Aug 08, 2023 $17.82 $18.82 $15.63 $18.52 425 951
Aug 07, 2023 $19.78 $19.98 $19.19 $19.34 210 712
Aug 04, 2023 $19.47 $20.02 $19.33 $19.82 191 837
Aug 03, 2023 $18.82 $19.65 $18.74 $19.46 139 192
Aug 02, 2023 $18.57 $19.06 $18.12 $18.89 143 399
Aug 01, 2023 $18.83 $19.14 $18.32 $18.64 125 683
Jul 31, 2023 $18.53 $19.10 $18.50 $18.97 127 631
Jul 28, 2023 $18.31 $18.58 $18.15 $18.44 148 453
Jul 27, 2023 $18.89 $18.89 $17.93 $18.12 246 491
Jul 26, 2023 $18.77 $19.10 $18.70 $18.83 152 374
Jul 25, 2023 $18.37 $18.92 $18.34 $18.59 322 277
Jul 24, 2023 $18.84 $18.95 $18.16 $18.43 183 570
Jul 21, 2023 $18.73 $18.89 $18.24 $18.80 168 425
Jul 20, 2023 $18.87 $19.00 $18.62 $18.66 155 977
Jul 19, 2023 $19.08 $19.27 $18.76 $18.97 186 012
Jul 18, 2023 $18.86 $19.48 $18.50 $19.05 147 468
Jul 17, 2023 $19.24 $19.63 $18.86 $18.88 193 219
Jul 14, 2023 $19.21 $19.33 $18.82 $19.22 150 999
Jul 13, 2023 $19.61 $19.64 $19.17 $19.20 191 943
Jul 12, 2023 $19.82 $19.86 $19.45 $19.56 128 428
Jul 11, 2023 $19.65 $19.65 $19.08 $19.46 203 217
Jul 10, 2023 $19.49 $20.19 $19.29 $19.61 245 231
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT